Botulinum neurotoxin serotype A inhibitors: Small-molecule mercaptoacetamide analogs
摘要:
Botulinum neurotoxin elicits its paralytic activity through a zinc-dependant metalloprotease that cleaves proteins involved in neurotransmitter release. Currently, no drugs are available to reverse the effects of botulinum intoxication. Herein we report the design of a novel series of mercaptoacetamide small-molecule inhibitors active against botulinum neurotoxin serotype A. These analogs show low micromolar inhibitory activity against the isolated enzyme. Structure-activity relationship studies for a series of mercaptoacetamide analogs of 5-amino-3-phenylpyrazole reveal components essential for potent inhibitory activity. (C) 2009 Elsevier Ltd. All rights reserved.
Botulinum neurotoxin serotype A inhibitors: Small-molecule mercaptoacetamide analogs
作者:Scott T. Moe、Andrew B. Thompson、Genessa M. Smith、Ross A. Fredenburg、Ross L. Stein、Alan R. Jacobson
DOI:10.1016/j.bmc.2009.03.013
日期:2009.4
Botulinum neurotoxin elicits its paralytic activity through a zinc-dependant metalloprotease that cleaves proteins involved in neurotransmitter release. Currently, no drugs are available to reverse the effects of botulinum intoxication. Herein we report the design of a novel series of mercaptoacetamide small-molecule inhibitors active against botulinum neurotoxin serotype A. These analogs show low micromolar inhibitory activity against the isolated enzyme. Structure-activity relationship studies for a series of mercaptoacetamide analogs of 5-amino-3-phenylpyrazole reveal components essential for potent inhibitory activity. (C) 2009 Elsevier Ltd. All rights reserved.